Specialty and rare disease audiences that outperform
Built differently for low-prevalence, high-value patient populations
Why specialty and rare disease targeting breaks
Traditional healthcare audiences rely on predictive models and lookalikes.
In low-prevalence populations, those approaches break down.
Models guess who looks like a patient
Low prevalence amplifies error
Missed patients mean wasted impressions
Built differently for specialty and rare disease
Blueprint takes a fundamentally different approach to healthcare audience targeting.
Instead of predicting who might be a patient, we focus on measuring real signal in low-prevalence populations. This approach prioritizes finding real patients over maximizing modeled scale.
No predictive models or lookalikes
No consumer behavior data
Designed to work where prevalence is low
Built for speed and control
Specialty and rare disease campaigns don't have room for trial and error.
Blueprint gives teams clarity early, so they can size audiences correctly and spend efficiently.
Same-day audience builds
Audience quality visible before spend
Right-size audiences based on budget, frequency, and platform
Run a specialty or rare disease test
Test Blueprint with a single specialty or rare disease audience.
See audience quality up front and measure performance before scaling.